PRICE T ROWE ASSOCIATES INC /MD/
Position in AVXL — Anavex Life Sciences Corp.
CIK 80255
BALTIMORE, MD
Position in AVXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$172,799
-$21,304 QoQ
Shares Held
66,718
+5.5% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. AVXL ranks #260 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in AVXL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,799 | 66,718 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $194,103 | 63,226 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $164,753 | 46,279 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $405,929 | 45,610 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $385,137 | 41,772 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $283,474 | 33,039 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $313,575 | 29,197 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $358,459 | 63,109 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $227,014 | 53,795 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $263,529 | 51,774 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $473,208 | 50,828 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $324,283 | 49,509 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $352,589 | 43,369 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $364,173 | 42,494 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $389,540 | 42,067 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $427,671 | 41,441 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $369,979 | 36,961 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $448,724 | 36,452 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $549,764 | 31,705 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $557,185 | 31,041 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $483,283 | 21,141 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $323,547 | 21,642 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $356,356 | 65,992 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $409,918 | 90,092 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $443,597 | 90,162 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $361,859 | 114,876 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||